v3.23.1
Basis of presentation and summary of significant accounting policies - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2022
Accounting Policies [Line Items]          
Cash current $ 33,000,000.0   $ 33,000,000.0   $ 41,300,000
Accounts receivable reserves recorded amount 0   $ 0   $ 0
Antidilutive securities excluded from the computation of earnings per share     7,207,203 4,560,901  
Kantaro Bio Sciences LLC Member          
Accounting Policies [Line Items]          
Performance of the contract liability $ 0 $ 30,000.00 $ 20,000.00 $ 160,000  
Equity method investment ownership percentage 25.00%   25.00%   25.00%
Software and Software Development Costs [Member]          
Accounting Policies [Line Items]          
Estimated useful life     10 years    
Share-based Payment Arrangement, Option [Member]          
Accounting Policies [Line Items]          
Antidilutive securities excluded from the computation of earnings per share 4,958,513   4,958,513 4,560,901  
Service [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]          
Accounting Policies [Line Items]          
Concentration risk, percentage     99.00%    
Service [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Mount Sinai [Member]          
Accounting Policies [Line Items]          
Concentration risk, percentage     73.00%    
Service [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Medicare Claims [Member]          
Accounting Policies [Line Items]          
Concentration risk, percentage     15.00%    
Service [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Other Party Payors [Member]          
Accounting Policies [Line Items]          
Concentration risk, percentage     12.00%